Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Clinical trial NCT05397600 · COMPLETED

Trial details

NCT number: NCT05397600
Sponsor: Laboratoires Thea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2022-06-22
Primary completion: 2024-03-07
Enrollment: 684

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.